Cargando…
COVID-19 and the health of people who use drugs: What is and what could be?
SARS-CoV-2, the virus that causes COVID-19, has changed the world as we know it, and continues to do so. How COVID-19 affects people who use drugs, the environments in which they live, and capacities of response, warrants immediate attention. This special issue begins to map how COVID-19 is altering...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837052/ https://www.ncbi.nlm.nih.gov/pubmed/33183679 http://dx.doi.org/10.1016/j.drugpo.2020.102958 |
_version_ | 1783642879576506368 |
---|---|
author | Grebely, Jason Cerdá, Magdalena Rhodes, Tim |
author_facet | Grebely, Jason Cerdá, Magdalena Rhodes, Tim |
author_sort | Grebely, Jason |
collection | PubMed |
description | SARS-CoV-2, the virus that causes COVID-19, has changed the world as we know it, and continues to do so. How COVID-19 affects people who use drugs, the environments in which they live, and capacities of response, warrants immediate attention. This special issue begins to map how COVID-19 is altering the health of people who use drugs, including in relation to patterns of drug use, service responses, harms that may relate to drug use, interventions to reduce risk of harms, COVID-19 health, and drug policies. We emphasise the need to envisage COVID-19 and its effects as a matter of intersecting ‘complex adaptive systems’: that is, the impacts of COVID-19 extend beyond the virus and related illness conditions to encompass multiple social, cultural, economic, policy and political effects; and these affect the health of people who use drugs directly as well as indirectly by altering the risk and enabling environments in which they live. We synthesize emergent evidence on the impact of COVID-19 on the health of people who use drugs. A key concern we identify is how to sustain policy and service delivery improvements prompted by COVID-19. We need to maintain an ethos of emergent adaptation and experimentation towards the creation of safer environments in relation to the health of people who use drugs. |
format | Online Article Text |
id | pubmed-7837052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78370522021-01-26 COVID-19 and the health of people who use drugs: What is and what could be? Grebely, Jason Cerdá, Magdalena Rhodes, Tim Int J Drug Policy Commentary SARS-CoV-2, the virus that causes COVID-19, has changed the world as we know it, and continues to do so. How COVID-19 affects people who use drugs, the environments in which they live, and capacities of response, warrants immediate attention. This special issue begins to map how COVID-19 is altering the health of people who use drugs, including in relation to patterns of drug use, service responses, harms that may relate to drug use, interventions to reduce risk of harms, COVID-19 health, and drug policies. We emphasise the need to envisage COVID-19 and its effects as a matter of intersecting ‘complex adaptive systems’: that is, the impacts of COVID-19 extend beyond the virus and related illness conditions to encompass multiple social, cultural, economic, policy and political effects; and these affect the health of people who use drugs directly as well as indirectly by altering the risk and enabling environments in which they live. We synthesize emergent evidence on the impact of COVID-19 on the health of people who use drugs. A key concern we identify is how to sustain policy and service delivery improvements prompted by COVID-19. We need to maintain an ethos of emergent adaptation and experimentation towards the creation of safer environments in relation to the health of people who use drugs. Elsevier B.V. 2020-09 2020-11-09 /pmc/articles/PMC7837052/ /pubmed/33183679 http://dx.doi.org/10.1016/j.drugpo.2020.102958 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Commentary Grebely, Jason Cerdá, Magdalena Rhodes, Tim COVID-19 and the health of people who use drugs: What is and what could be? |
title | COVID-19 and the health of people who use drugs: What is and what could be? |
title_full | COVID-19 and the health of people who use drugs: What is and what could be? |
title_fullStr | COVID-19 and the health of people who use drugs: What is and what could be? |
title_full_unstemmed | COVID-19 and the health of people who use drugs: What is and what could be? |
title_short | COVID-19 and the health of people who use drugs: What is and what could be? |
title_sort | covid-19 and the health of people who use drugs: what is and what could be? |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837052/ https://www.ncbi.nlm.nih.gov/pubmed/33183679 http://dx.doi.org/10.1016/j.drugpo.2020.102958 |
work_keys_str_mv | AT grebelyjason covid19andthehealthofpeoplewhousedrugswhatisandwhatcouldbe AT cerdamagdalena covid19andthehealthofpeoplewhousedrugswhatisandwhatcouldbe AT rhodestim covid19andthehealthofpeoplewhousedrugswhatisandwhatcouldbe |